Northeast Investment Management Sells 6,822 Shares of Danaher Co. (NYSE:DHR)

Northeast Investment Management lowered its stake in Danaher Co. (NYSE:DHR - Free Report) by 3.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 168,393 shares of the conglomerate's stock after selling 6,822 shares during the quarter. Danaher comprises about 1.6% of Northeast Investment Management's portfolio, making the stock its 20th biggest holding. Northeast Investment Management's holdings in Danaher were worth $34,521,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth about $27,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new position in Danaher in the fourth quarter worth approximately $31,000. Pineridge Advisors LLC increased its holdings in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after buying an additional 57 shares during the last quarter. Finally, Kentucky Trust Co bought a new stake in Danaher during the fourth quarter worth approximately $34,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent analyst reports. The Goldman Sachs Group decreased their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. UBS Group reduced their target price on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research note on Monday, June 9th. HSBC reduced their price objective on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Finally, Robert W. Baird lowered their price target on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $248.17.

Danaher Stock Down 2.2%

Shares of DHR stock traded down $4.59 during trading hours on Friday, hitting $200.51. 3,391,410 shares of the company were exchanged, compared to its average volume of 3,490,806. The business has a 50 day moving average of $192.80 and a two-hundred day moving average of $211.00. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a market capitalization of $143.50 billion, a PE ratio of 37.98, a PEG ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.64%. Danaher's dividend payout ratio is currently 24.85%.

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.